The story of Sildenafil presents a complex picture for those considering investment. While the initial launch generated significant profits, the end of its patent opened the door to off-brand versions, dramatically https://socialbraintech.com/story6643455/sildenafil-and-the-pharmaceutical-industry-a-risky-opportunity